Eli Lilly and Company
Prescription Drugs · Cardiometabolic Therapeutics

Eli Lilly and Company: Risk & public record

Eli Lilly and Company: 5,627 research papers in five years, 3 competition cases, 52k lb of toxic releases at 2 US sites (EPA TRI, 2024), $10.6M of EU lobbying in 2025.

Data updated Nov 22, 2026 · Back to the company report

What the registers and the postings say about this employer.

Legal entity active
Eli Lilly and Company · dol.gov ↗
Not checked
Postings are real
Alion truth index: A
93/100
Ghost roles
re-checked against its careers site
0%
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Domain in use
lilly.com: first seen in registries and web archives · lookup.icann.org ↗
since 1997
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Domain and mail securitylilly.com · Nov 14, 2026
Spoofed mail (DMARC)
Spoofed mail is rejected · dns.google ↗
Good
Who may send its mail (SPF)
Neutral: says nothing about other senders (?all) · dns.google ↗
Weak
HTTPS certificate
The certificate expires within two weeks · crt.sh ↗
Weak
HTTPS enforced (HSTS)
Enforced for a short time only · hstspreload.org ↗
Weak
Security contact (security.txt)
No security.txt · lilly.com ↗
Weak
Encrypted mail delivery (MTA-STS)
No MTA-STS policy · dns.google ↗
Weak
Signed DNS (DNSSEC)
Not signed · dnsviz.net ↗
Weak
Certificate issuers (CAA)
Any authority may issue certificates · dns.google ↗
Weak
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices The domain: its DNS records, its site's headers and certificate.

Public record

Eli Lilly and Company: 5,627 research papers in five years, 3 competition cases, 52k lb of toxic releases at 2 US sites (EPA TRI, 2024), $10.6M of EU lobbying in 2025.

Research outputpapers its people wrote, per OpenAlex
5,627papers in five years
1.6Mcitations
Diabetes Treatment and Management
Medicine
1,893 papers
Diabetes Management and Research
Medicine
1,461 papers
Pharmacogenetics and Drug Metabolism
Pharmacology, Toxicology and Pharmaceutics
1,322 papers
Alzheimer's disease research and treatments
Neuroscience
1,320 papers
Neuroscience and Neuropharmacology Research
Neuroscience
1,314 papers

Works most with: Harvard University, Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, Pfizer (United States), Mass General Brigham, F. Hoffmann-La Roche AG

Competition casesthe European Commission's merger, antitrust and cartel cases and the UK CMA's cases naming it
ELI LILLY / NOVARTIS ANIMAL HEALTH
European Commission M.7277 · merger · Art. 6(1)(b) · cleared · Normal · Oct 2014
ELI LILLY / JANSSEN PHARMACEUTICA ANIMAL HEALTH BUSINESS ASSETS
European Commission M.6205 · merger · Art. 6(1)(b) · cleared · Normal · Jul 2011
ELI LILLY / CERTAIN ANIMAL HEALTH ASSETS OF PFIZER
European Commission M.5843 · merger · Art. 6(1)(b) · cleared · Simplified · May 2010
Toxic releases (EPA TRI)its US facilities' releases to air, water and land, as they report them to the EPA
Lilly Del Caribe Inc Carolin A
Carolina, PR · nitrate compounds (water dissociable; reportable only when i, acetonitrile, ammonia · 49 lb of carcinogens · 2024
35k lb
Lilly Technology Center
Indianapolis, IN · acetonitrile, methyl tert-butyl ether, n,n-dimethylformamide · 3k lb of carcinogens · 2024
17k lb
Influence
US lobbying
2025 · CHECKMATE GOVERNMENT RELATIONS $400,000, Tiber Creek Health Strategies, Inc · disclosurespreview.house.gov ↗
$10.6M
EU lobbying, declared
2025 · Acumen Public Affairs, Acento Public Affairs, CONCILIUS AG, Vulcan Consulting Limited, Covington & Burling LLP, Fleishman-Hillard, DGA Grou… · transparency-register.europa.eu ↗
EUR 900,000–999,999
Patents
Published US applications
52
Regulators
FDA warning letters
Sep 2025 · Center for Drug Evaluation and Research (CDER) · Eli Lilly and Company
Sep 2025 · Center for Drug Evaluation and Research (CDER) · Eli Lilly and Company
Sep 2025 · Center for Drug Evaluation and Research (CDER) · Eli Lilly and Company
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener. The fines as the CMS GDPR Enforcement Tracker lists them, each linking the authority’s decision; recalls from the FDA’s enforcement reports.